JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Surgical treatment of iliotibial band friction syndrome. A retrospective study of 45 patients.

Iliotibial band friction syndrome is an overuse injury mainly affecting runners, but also other athletes. The treatment of choice is conservative. If this treatment is unsuccessful, surgical treatment can be performed. The posterior half of the iliotibial band is transsected where it passes over the lateral epicondyle of the femur. Optionally the underlying bursa is removed. Between 1989 and 1996 45 patients were operated in Trondheim. The mean age was 27 (14-46) years. Of the patients, 22 (48.9%) had excellent results, 16 (35.5%) had good results, 6 (13.3%) had fair results and 1 (2.2%) patient had a poor result. One patient had a minor postoperative infection. Had the postoperative result been known beforehand, 75.6% of the patients would have been operated on again. We conclude that surgical treatment of iliotibial band friction syndrome produces good results in patients with insufficient relief of symptoms after conservative treatment.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app